The risks and rewards of gene-editing

Robin Lovell-Badge, developmental biologist and geneticist, talks to FT science columnist Anjana Ahuja about the gene-edited babies controversy in China and about the potential for new gene-editing techniques to transform the treatment of diseases like cancer and muscular dystrophy.

Hosted on Acast. See acast.com/privacy for more information.